Senior Living At Sussex Healthcare

If you are looking for a facility where you can place your elderly loved one, you will find that there are many to choose from and they all offer many different things. At Sussex Healthcare, you will find they offer most everything your loved one will need. The medical care they will receive while living there is excellent and they have a wide variety of activities to keep your family member busy.

Sussex Healthcare has been in business for over twenty five years and they have locations throughout the United Kingdom. Sussex Healthcare has received many awards for excellence over the years and they continue to improve their services. They have an excellent computer system where information is kept, in confidentiality, so that it is easy to review when needed. The facilities offer private or semi private rooms which are very spacious and with modern furnishings. More about of Sussex Healthcare at Companies House.

The management team at Sussex Healthcare are highly qualified individuals and provide much support to the medical team. They have many years of experience working in facilities of this type and bring their expertise to Sussex in order to make it the best residential and nursing care facility. The management team works diligently with family members in order to make every resident comfortable.

Residents are evaluated repeatedly in order to determine the best possible treatments for them and are encouraged to participate in as many activities as they are able to do. Activities are selected depending on their interests and ability to participate. Residents may also enjoy many of the planned trips that Sussex Healthcare providers offer.

With the number of facilities that are available, Sussex is sure that you will find the right one for your family member and will be more than happy to allow you to visit any of them at any time. You can make arrangements for a visit with the admitting department who will arrange for you to meet with a member of management. They will take you on a tour of the facility and answer any questions you may have. Contact them in order to see what they have to offer.

Visit: https://sussexhealthcare.jobs.net/

 

Dr. Mark Mofid; Innovator of Ground-Breaking Safer Gluteal Implants

Dr. Mark Mofid, a board-certified plastic surgeon in La Jolla, California, is known for his dedication to his patients. His extensive research on the safety of gluteal implants is changing the industry by using approaches supported by science. Dr. Mofid realized that one of the main problems with gluteal augmentation is that the implants were generic and incompatible with the body’s muscle structure which in turn would sag, defeating the whole purpose of the procedure. Dr. Mark Mofid researched, invested, and brainstormed to create an effective gluteal implant for his clients.

The new gluteal implant has a low profile, superior intramuscular positioning, and is up-to-date considering the previous implants. It has overcome the industry and is pursued by many other doctors and also consumers. In the past, the gluteal augmentation industry had a bad reputation and some bad stories to support it. But with Dr. Mark Mofid’s new design, he gained the confidence back from the industry. Brazil is known for having a high number of these operations so Dr. Mark Mofid confided with a Brazilian doctor who also specializes in gluteal augmentation.

Other than being known for creating an effective gluteal implant, his office also offers breast and facial surgeries, liposuction, laser hair removal, and vein treatments. They offer facial rejuvenation, which is what some patients prefer rather than a surgical procedure. This allows the patient to test the waters before something permanent is performed. Many patients like the outcome and will consider a surgical procedure later on. He works alongside his wife, who is a dermatologist at the practice. When it comes to advertising, rather than spending an enormous amount, Dr. Mark Mofid believes that word of mouth is the best form. Patient referrals are what keeps the business alive, not advertising.

Dr. Mark Mofid graduated from Harvard University and received his medical degree from The Johns Hopkins University School of Medicine. He has had his practice since 2004.

https://www.doximity.com/pub/m-mofid-md

Dr. Jim Tananbaum: Scientist, Investor, Genius

Dr. Jim Tananbaum attended Yale University, Harvard Medical School and the Massachusetts Institute of Technology (MIT). He earned a B.S. and B.S.E.E. from Yale, an M.D. from Harvard, an M.S. from MIT an M.B.A from Harvard, and a Master’s of Science (M.S.) M.S. from MIT.

Dr. Jim Tananbaum invests in the health and pharmaceutical sectors with 25 years of being a healthcare entrepreneur and investment strategist. He is strategic in his investments with the goal to build franchise healthcare enterprises.

With so many business opportunities at his fingertips, he founded and is the CEO and Managing Director of Foresite Capital, which provides growth capital to healthcare innovators that seek to transform patient care.

Dr. Tananbaum could not do this all alone. He sought the mentoring of his partners. Rick Levin from Yale, Rick Klausner from the National Cancer Institute, Roy Vagelos, from Merck and Theravance, Bob Gunderson, Gunderson Detmer and George Whitesides, Harvard

Dr. Tananbaum invested and invested in 10x Genomics, Intarcia Therapeutics, Aerie Pharmaceuticals and Aimmune Therapeutics and Amira Pharmaceuticals. He founded two pharmaceuticals, GelTex Pharmaceuticals and Amira Pharmaceuticals and co-founded and was the CEO of Theravance, Inc. and its spin-off Theravance Biopharma, Inc.

His healthcare investment experience also included being a partner at Sierra Ventures, where he established healthcare services investment practice. He also was a founding partner of Prospect Venture Partners II and III, which specialized in investments in healthcare and biotechnology. You can visit Forbes to know more.

Dr. Tananbaum has done well in his investments. For instance, GelTex was acquired for $1.6 billion in 1998. Its primary drug, Renagel (Renzela), initially earned more than $200 million annual revenue. Renzela’s value now is estimated to be close to $1 billion in annual income. He also has several more significant investments such as Intarcia Therapeutics innovative treatment for diabetes and Puma Biotechnology and Aimmune, a food allergy immunotherapy treatment, which will produce a multi-million dollar, return on Foresite Capital investments which led a Series B round of $80 million in 2015.

Dr. Tananbaum goal is to find the brightest thought-provoking leaders in healthcare and to provide them with the means to make decisive scientific discoveries to have a maximum impact on healthcare. More details can be found on Ideamensch.

See more: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund

Check out the website officialjimtananbaum.com